We are live on ! Find out more
BMGL icon

Basel Medical

9 hedge funds and large institutions have $70.2K invested in Basel Medical in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.81% less ownership

Funds ownership: 1.57% → 0.76% (-0.81%)

10% less funds holding

Funds holding: 10 → 9 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

68% less capital inflows, than outflows

Capital inflows: $138K | Capital outflows: $428K

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BMGL Hedge Fund Activity: Q4 2025 in Review

9 of the 8,309 institutional investors tracked by Wall St. Rank reported a position in Basel Medical (BMGL) for Q4 2025, worth a combined $70.2K — down 87% from $525K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BMGL and 5 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Ground Swell Capital, opening a new position worth an estimated $41.5K. The largest seller was Morgan Stanley, exiting entirely with an estimated $135K sold.

  • 9 institutional investors held Basel Medical (BMGL) as of Q4 2025, down from 10 in Q3 2025.
  • Funds reported $70.2K of Basel Medical stock for Q4 2025, down 87% quarter-over-quarter.
  • 5 funds opened new Basel Medical positions in Q4 2025 and 6 closed out, a net change of -1 holder.
  • The largest Basel Medical buyer in Q4 2025 was Ground Swell Capital, an estimated $41.5K added.
  • The largest Basel Medical seller in Q4 2025 was Morgan Stanley, an estimated $135K sold.

Based on aggregated 13F filings for Q4 2025.